Harm perceptions of e-cigarettes and other nicotine products in a UK sample.
Adolescent
Adult
Attitude to Health
Culture
Electronic Nicotine Delivery Systems
Female
Harm Reduction
Health Knowledge, Attitudes, Practice
Health Surveys
Humans
Longitudinal Studies
Male
Middle Aged
Smoking
/ adverse effects
Smoking Cessation
Tobacco Use Cessation Devices
/ adverse effects
United Kingdom
Vaping
/ adverse effects
Young Adult
Electronic cigarettes
electronic nicotine delivery systems
harm perception
harm reduction
nicotine replacement products
smoking
vaping
Journal
Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
30
05
2018
revised:
22
08
2018
accepted:
14
11
2018
pubmed:
5
1
2019
medline:
17
6
2020
entrez:
5
1
2019
Statut:
ppublish
Résumé
E-cigarettes (EC) and nicotine replacement therapy (NRT) are less harmful than smoking, but misperceptions of relative harm are common. Aims were to (1) assess nicotine knowledge and perceptions of: harm of EC and NRT relative to smoking, addictiveness of EC relative to smoking, and change in harm to user if smoking replaced with EC; (2) define associations of these perceptions with respondent characteristics including nicotine knowledge; and (3) explore perceived main harms of EC and whether these differ by vaping status. Analyses were: (1) frequencies; (2) logistic regressions of perceptions of relative harm, addictiveness and change in harm onto demographics, smoking and vaping status and nicotine knowledge (attributing cancer or health risks of smoking to nicotine); and (3) frequencies and χ Participants were smokers and recent ex-smokers from one wave (September 2017) of a longitudinal online survey in the United Kingdom (n = 1720). Demographics included gender, age, smoking status, vaping status and income. Survey questions collected data on nicotine knowledge and harm perceptions of different products; the relative harm perceptions of NRT, EC and tobacco cigarettes; and perceived main harms of EC. Relative to smoking, 57.3% perceived EC and 63.4% NRT to be less harmful; 25.4% perceived EC to be less addictive; and 32.2% thought replacing smoking with EC reduced health harms a great deal. Participants were less likely to endorse these beliefs if they had never vaped, and participants who had inaccurate nicotine knowledge were less likely to endorse all these beliefs apart from the addictiveness of EC. The main concerns about EC were a lack of research (48.3%), regulation or quality control (37.8%) and harmfulness of chemicals (41.6%). Large proportions of UK smokers and ex-smokers overestimate the relative harmfulness of e-cigarettes and nicotine replacement therapy compared with smoking; misattributing smoking harms to nicotine is associated with increased misperceptions.
Sections du résumé
BACKGROUND AND AIMS
E-cigarettes (EC) and nicotine replacement therapy (NRT) are less harmful than smoking, but misperceptions of relative harm are common. Aims were to (1) assess nicotine knowledge and perceptions of: harm of EC and NRT relative to smoking, addictiveness of EC relative to smoking, and change in harm to user if smoking replaced with EC; (2) define associations of these perceptions with respondent characteristics including nicotine knowledge; and (3) explore perceived main harms of EC and whether these differ by vaping status.
DESIGN
Analyses were: (1) frequencies; (2) logistic regressions of perceptions of relative harm, addictiveness and change in harm onto demographics, smoking and vaping status and nicotine knowledge (attributing cancer or health risks of smoking to nicotine); and (3) frequencies and χ
SETTING AND PARTICIPANTS
Participants were smokers and recent ex-smokers from one wave (September 2017) of a longitudinal online survey in the United Kingdom (n = 1720).
MEASUREMENTS
Demographics included gender, age, smoking status, vaping status and income. Survey questions collected data on nicotine knowledge and harm perceptions of different products; the relative harm perceptions of NRT, EC and tobacco cigarettes; and perceived main harms of EC.
FINDINGS
Relative to smoking, 57.3% perceived EC and 63.4% NRT to be less harmful; 25.4% perceived EC to be less addictive; and 32.2% thought replacing smoking with EC reduced health harms a great deal. Participants were less likely to endorse these beliefs if they had never vaped, and participants who had inaccurate nicotine knowledge were less likely to endorse all these beliefs apart from the addictiveness of EC. The main concerns about EC were a lack of research (48.3%), regulation or quality control (37.8%) and harmfulness of chemicals (41.6%).
CONCLUSIONS
Large proportions of UK smokers and ex-smokers overestimate the relative harmfulness of e-cigarettes and nicotine replacement therapy compared with smoking; misattributing smoking harms to nicotine is associated with increased misperceptions.
Identifiants
pubmed: 30609154
doi: 10.1111/add.14502
pmc: PMC6491935
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
879-888Subventions
Organisme : Medical Research Council
ID : MR/K023195/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C57277/A23884
Pays : United Kingdom
Organisme : United Kingdom Clinical Research Collaboration
ID : MR/K023195/1
Pays : International
Organisme : Cancer Research UK
ID : C52999/A21496
Pays : United Kingdom
Informations de copyright
© 2019 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Références
Tob Control. 2006 Jun;15 Suppl 3:iii65-70
pubmed: 16754949
Drug Alcohol Depend. 2015 Dec 1;157:106-11
pubmed: 26507173
Harm Reduct J. 2011 Aug 23;8:21
pubmed: 21859499
Am J Prev Med. 2017 Mar;52(3):339-346
pubmed: 27890516
Addiction. 2012 Nov;107(11):2037-42
pubmed: 22632274
Nicotine Tob Res. 2009 Sep;11(9):1076-82
pubmed: 19571249
Public Health. 2017 Aug;149:45-48
pubmed: 28531448
Tob Control. 2017 Mar;26(e1):e49-e58
pubmed: 27625408
Addiction. 2019 May;114(5):879-888
pubmed: 30609154
BMC Public Health. 2011 Jun 18;11:479
pubmed: 21682915
Am J Prev Med. 2017 Mar;52(3):331-338
pubmed: 28341303
Lancet. 2015 Sep 26;386(10000):1237
pubmed: 26338257
Ann Intern Med. 2017 Mar 21;166(6):390-400
pubmed: 28166548
BMJ. 2014 Nov 26;349:2014.7.0264rep
pubmed: 25428425